MI-3454
MI-3454 is an orally active, selective and potent inhibitor of Menin-MLL1 interaction that inhibits the proliferation and induces differentiation of acute leukemia cells with MLL1 translocation or NPM1 mutation.MI-3454 induces complete remission or regression of leukemia in a mouse model of leukemia with MLL1 rearrangement or NPM1 mutation through the down-regulation of key genes involved in leukemogenesis. complete remission or remission.
Product Specifications
CAS Number
2134169-43-8
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
636.73
Molecular Formula
C32H35F3N8OS
Notes
Research use only, not for human use.
Receptor
Histone Methyltransferase
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
18210141 1x 10^6 Cells / 1.0 mL
DHX8 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details 
